- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02805712
Focused Palliative Care Intervention in Advanced Heart Failure
Pilot Study of a Focused Palliative Care Intervention for Recently Hospitalized High-Risk Patients With Heart Failure
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Patients will be assigned to one of two groups a) longitudinal goals of care discussion led by a palliative care-trained social worker or b) usual care + written information regarding advanced directives. The intervention group will be enrolled in the hospital and then be followed longitudinally for 3 months by a palliative care-trained social worker who will shepherd a conversation around prognosis, expectations, and goals of care. The results of these conversations will be documented in the electronic medical record and shared with the clinical team. Clinical symptoms that are identified during these conversations will be evaluated by a Palliative Care Physician who will relay suggestions regarding management to the primary treating clinician. Baseline surveys will assess prognostic awareness, symptom burden, anxiety, depression, and quality of life for both groups. At the conclusion of the study, an individualized follow-up plan will be devised for each patient based on a needs assessment by the study social worker.
Patients assigned to the control/usual care arm will complete the same series of questionnaires as those assigned to the intervention group and will undergo usual in hospital and post-discharge treatment as directed by their care team. All control subjects will receive written Advanced Care planning and Heart Failure education materials as provided routinely to inpatients at Brigham and Women's Hospital. At the 6 month visit following hospitalization, these patients will be asked to complete follow up questionnaires and then will be given the option to participate in the above verbal intervention and guided "Goals and Values" conversation that was provided to the intervention group.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02115
- Brigham and Women's Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria
- Symptomatic Heart Failure (NYHA II-IV)
Hospitalized or recently for acute decompensation with at least one of the following high-risk features
- Prior hospitalization for Heart Failure (HF) within 1 year
- Age > 80 years
- Chronic Kidney Disease (estimated Glomerular Filtration Rate (eGFR) < 45 mL/min/m2)
- Systolic Blood Pressure < 100 mm Hg
- Serum sodium < 130 meq/L
- Cardiogenic Shock (Cardiac Index < 2.0)
- Serious Non-Cardiovascular Illness (e.g. advanced stage cancer, Chronic Obstructive Pulmonary Disease (COPD) , or the like.
- Ability to Provide Informed Consent
- Permission of attending physician
Exclusion Criteria
- Anticipated major cardiac surgery, including Ventricular Assist Device (VAD) or transplant, within 3 months of enrollment
- Already enrolled in hospice or receiving outpatient palliative care
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Comparatore attivo: Control
Participant will receive usual care for Heart Failure patients, which include standard written material on Advanced Care planning and supportive cardiology/palliative care consult if ordered by attending.
|
The control group will receive usual written care material and a palliative care consult if ordered by physician.
|
Sperimentale: Verbal Information and Discussion
Participants will participate in a guided goals of care conversation and the support of a Palliative Care Social Worker who is working closely with the patients' primary cardiology team.
Social worker has ongoing clinical review of participants with a Palliative Care physician who will provide a full medical consult if appropriate.
|
Intervention patient will receive a outpatient session with a palliative care social worker in the heart failure clinic two weeks post discharge consent focusing on goals of care.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Is there a change in patient understanding of prognosis with the addition of a palliative care intervention?
Lasso di tempo: 6 months
|
Assessment tool: Patient Preferences Questionnaire.
|
6 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Is there an impact on documentation of advanced care planning documentation with a palliative care intervention?
Lasso di tempo: 6 months
|
Chart review of Advanced Care Planning documents and written notes by members of clinical team.
|
6 months
|
Is there an impact on symptom burden through a palliative care intervention?
Lasso di tempo: Three months
|
Assessment tool: : The Kansas City Cardiomyopathy Questionnaire (KCCQ-12)
|
Three months
|
Is there an impact on perceived level of illness through a palliative care intervention?
Lasso di tempo: 6 months
|
Assessment tool: EQ visual analogue scale (EQ-VAS)
|
6 months
|
Is there an impact on overall patient well being through a palliative care intervention?
Lasso di tempo: Three months
|
Assessment tool: The Functional Assessment of Chronic Illness Therapy ( FACIT-Sp)
|
Three months
|
Is there an impact on depression through a palliative care intervention?
Lasso di tempo: 6 months
|
Assessment tool: Patient Health Questionnaire (PHQ-8)
|
6 months
|
Is there an impact on anxiety through a palliative care intervention?
Lasso di tempo: 6 months
|
Assessment tool: General Anxiety Disorder (GAD-7)
|
6 months
|
Is there an impact on cost of treatment through a palliative care intervention?
Lasso di tempo: 6 months
|
Focus will be on cost through health care utilization as aggregated by number of hospital days, days in ICU and 30 day re-admissions.
|
6 months
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Akshay S Desai, MPH, MD, Brigham and Women's Hospital
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 2014P001391
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Arresto cardiaco
-
Region SkaneIscrizione su invitoInsufficienza cardiaca Classe II della New York Heart Association (NYHA). | Insufficienza cardiaca Classe III della New York Heart Association (NYHA).Svezia
-
Medical University of BialystokInstitute of Cardiology, Warsaw, Poland; Medical University of Lodz; Poznan University... e altri collaboratoriNon ancora reclutamentoInsufficienza cardiaca, sistolica | Insufficienza cardiaca con frazione di eiezione ridotta | Scompenso cardiaco Classe IV della New York Heart Association | Scompenso cardiaco Classe III della New York Heart AssociationPolonia
-
University of WashingtonAmerican Heart AssociationCompletatoInsufficienza cardiaca, congestizia | Alterazione mitocondriale | Scompenso cardiaco Classe IV della New York Heart AssociationStati Uniti
Prove cliniche su Control
-
University of California, Los AngelesCompletatoDiabete di tipo 2Stati Uniti
-
Johns Hopkins UniversityCompletato
-
University of Southern CaliforniaPendulum TherapeuticsRitiratoDiabete di tipo 2 | Sintomi gastrointestinaliStati Uniti
-
Rethink Medical SLReclutamentoQualità della vita | Complicanza correlata al catetere | Infezione del tratto urinario associata a catetereSpagna
-
Rethink Medical SLRitiratoRitenzione urinaria | Complicazioni del catetere | Infezione del tratto urinario associata a catetereSpagna
-
Nephera Ltd.SconosciutoInsufficienza renale | Insufficienza cardiaca, congestizia | Scompenso cardiacoIsraele
-
Icahn School of Medicine at Mount SinaiReclutamento
-
Ulrike WillutzkiUniversity of BernReclutamentoDisordini mentali | Intervento onlineGermania
-
Devicare S.L.Clever Instruments S.L.; Fundacio PuigvertSconosciuto
-
Gonzalez-Heydrich, Joseph, M.D.Boston Children's Hospital; Harvard UniversityCompletatoLa rabbia | AggressioneStati Uniti